期刊文献+

用于治疗胃癌的靶向药物进展 被引量:1

Advances in Targeting Drugs for Accurate Therapy of Gastric Cancer
下载PDF
导出
摘要 胃癌是全球发病率第五位的恶性肿瘤,致死率仅次于肺癌、肝癌居第三位。化疗是目前进展期胃癌的主要治疗手段,但其联合化疗方案并没有从根本上提高化疗有效率。通过对胃癌发生、发展、复发和转移过程中分子生物机制的研究,分子靶点药物治疗应运而生,分子靶向治疗很大程度上提高了胃癌治疗的有效率。本文主要综述了胃癌靶点及其相关靶向药物。 Gastric cancer is the fifth global incidence of malignant tumors,lethal rate ranks third,which is just after lung cancer and liver cancer. Chemotherapy is currently the main treatment of advanced gastric cancer, but the combined chemotherapy couldn t improve treatment efficiency fundamentally. Molecular target drug therapy is born at the right time through studying the molecular biological mechanism in the occurrence, development,recurrence and metastasis of gastric cancer. In this paper, the gastric cancer target and related drugs was summarized.
出处 《山东化工》 CAS 2017年第15期62-63,65,共3页 Shandong Chemical Industry
关键词 胃癌 分子靶向治疗 靶向药物 gastric cancer molecular targeted therapy targeted drugs
  • 相关文献

参考文献2

二级参考文献54

  • 1刘淑英,王晓稼.贝伐单抗在肿瘤治疗中相关毒副反应[J].肿瘤学杂志,2009,15(12):1133-1135. 被引量:3
  • 2胡大一,刘梅林,郭艺芳.老年高血压的诊断与治疗中国专家共识(2011版)[J].中国医学前沿杂志(电子版),2012,4(2):31-39. 被引量:101
  • 3Kobel M, Weichert W, Crtiwell K, Schmitt WD, Lautenschl~iger C, Hauptmann S. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004; 445: 456-464.
  • 4Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, el al. Caspase-mediated cleavage coilvcrts Hvin from an anfiapoptotic to a proapo ptotie factor: implications for drugresistant melanoma. Cancer Res 2003; 63: 6340-6349.
  • 5Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D. Two splicing variants ofanew inhibitor of apoptosis gene with diferent biological properties and tissue distribution pattern. FEBS Lett 2001; 495: 56-60.
  • 6Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P, et al. Hepatocyte growth actor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell 2007; 18: 76-83.
  • 7Li GS, Yao HT, Wang SQ. The relationship between the expression of CD44v6, vascular endothelial growth factor-C and lymphnode metastasis of gastric cancer. Chin J Clin Drug Res (Chin) 2005; 137: 14797-14798.
  • 8Carvalho R, Milne AN, Polak M, Offerhaus GJ, Weterman MA. A novel region of amplification at 11p12-13 in gastric ancer, revealed by representational diference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas, Genes Chromosomes Cancer 2006; 45: 967-975.
  • 9Gu HP, Shang PZ. Expression and correlation of biotin and CD44v6 protein in gastric cancer. J Xi'an Jiaotong Univ (Med Ed) (Chin) 2007; 28: 415-417.
  • 10Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, et al. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 2005; 11: 3309-3314.

共引文献369

同被引文献16

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部